tiprankstipranks
Advertisement
Advertisement
LCTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsLCTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
Premium
The Fly
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
1M ago
Lineage Cell Therapeutics initiated with a Buy at Canaccord
Premium
The Fly
Lineage Cell Therapeutics initiated with a Buy at Canaccord
2M ago
Lineage Therap Expands ATM Equity Offering Capacity
PremiumCompany AnnouncementsLineage Therap Expands ATM Equity Offering Capacity
3M ago
Lineage Cell Therapeutics Extends Runway Amid R&D Surge
Premium
Company Announcements
Lineage Cell Therapeutics Extends Runway Amid R&D Surge
3M ago
Regulatory Risks Loom for Lineage Cell Therapeutics as Legacy Pluripotent Cell Lines Face Potential Compliance Challenges
Premium
Company Announcements
Regulatory Risks Loom for Lineage Cell Therapeutics as Legacy Pluripotent Cell Lines Face Potential Compliance Challenges
3M ago
De-Risked Cell Therapy Platform and Roche Partnership Momentum Underpin Buy Rating on Lineage (LCTX)
PremiumRatingsDe-Risked Cell Therapy Platform and Roche Partnership Momentum Underpin Buy Rating on Lineage (LCTX)
5M ago
Lineage Cell Therapeutics receives iPSC line from Factor Bioscience
Premium
The Fly
Lineage Cell Therapeutics receives iPSC line from Factor Bioscience
5M ago
Lineage Therap Withdraws CIRM Grant Application
Premium
Company Announcements
Lineage Therap Withdraws CIRM Grant Application
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100